lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: 18-75; 2. Patients have confirmed lung cancer by histopathological methods(fiber, bronchoscopy, lung biopsy, open chest biopsy, pleural effusion exfoliated cells, sputum exfoliated cells); 3. After clinical assessment, patients who need chemoradiotherapy (tumor stage IIIb or IV of lung cancer) or others who are reluctant to receive pneumonectomy; 4. Patients have no previous history of chemoradiotherapy; 5. Patients with at least one clearly measurable lung lesion (lesion size larger than 10mm, by spiral CT, according to RECIST criteria); 6. Health status scoring between 0-2 by ECOG method; 7. Patients voluntarily to join this study and signed informed consents.
Exclusion criteria
Exclusion criteria: 1. Any body metal implants (pacemaker implantation, nerve stimulator, vascular stent, aneurysm clip, eye foreign body, the inner metal prosthesis) or artificial heart valves; 2. Patients with claustrophobia to MRI or CT examination; 3. Patients who are reluctant to comply with follow-up and subsequent examination; 4. The other condition that do not meet the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Accuracy;receiver operating characteristic curve;ADC value; | — |